Cancer vaccine from Austria: “Approval by 2029 realistic” Link: Krebsimpfstoff aus Österreich: "Zulassung bis 2029…
Science that gives hope. New cancer treatment options are presented on World Cancer Day in…
Our Head of R&D and CMO Ingrid Rauter met with Krems Bioanalytics to discuss key R&D projects for the…
Vaccentis AG,
Gerechtigkeitsgasse 25, CH - 8001 Zürich
